Resumption of Spermatogenesis and Fertility Post Withdrawal of Hydroxyurea Treatment

Hydroxyurea (HU), a drug for treating cancers of the blood and the management of sickle cell anemia, induces hypogonadism in males. However, the impact of HU on testicular architecture and function, as well as its effects on the resumption of male fertility following treatment withdrawal, remain poo...

Descripción completa

Detalles Bibliográficos
Autores principales: Virgous, Carlos, Lyons, Letitia, Sakwe, Amos, Nayyar, Tultul, Goodwin, Shawn, Hildreth, James, Osteen, Kevin, Bruner-Tran, Kaylon, Alawode, Oluwatobi, Bourne, Phillip, Hills, Edward Richard, Archibong, Anthony E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253555/
https://www.ncbi.nlm.nih.gov/pubmed/37298325
http://dx.doi.org/10.3390/ijms24119374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253555/
https://www.ncbi.nlm.nih.gov/pubmed/37298325
http://dx.doi.org/10.3390/ijms24119374

Ejemplares similares